Why SCHD’s Income Is Unshakable This Year: 6 Dividend Aristocrats Doing the Heavy Lifting

Summary

Article discusses the Schwab U.S. Dividend Equity ETF (SCHD) and six Dividend Aristocrats supporting its income this year, with Abbott Laboratories among the known tickers. Only the headline and an image were provided, so no biotech-specific data or catalysts are available.